259 related articles for article (PubMed ID: 33892432)
1. Prognostic impact of conservative surgery for pancreatic IPMNs.
Palmeri M; Di Franco G; Bianchini M; Guadagni S; Gianardi D; Furbetta N; Caprili G; Fatucchi LM; Sbrana A; Funel N; Pollina LE; Di Candio G; Morelli L
Surg Oncol; 2021 Sep; 38():101582. PubMed ID: 33892432
[TBL] [Abstract][Full Text] [Related]
2. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
3. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.
Tamura K; Ohtsuka T; Ideno N; Aso T; Shindo K; Aishima S; Ohuchida K; Takahata S; Ushijima Y; Ito T; Oda Y; Mizumoto K; Tanaka M
Ann Surg; 2014 Feb; 259(2):360-8. PubMed ID: 23989056
[TBL] [Abstract][Full Text] [Related]
5. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
[TBL] [Abstract][Full Text] [Related]
6. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
[TBL] [Abstract][Full Text] [Related]
7. Parenchyma-sparing pancreatectomy for presumed noninvasive intraductal papillary mucinous neoplasms of the pancreas.
Sauvanet A; Gaujoux S; Blanc B; Couvelard A; Dokmak S; Vullierme MP; Ruszniewski P; Belghiti J; Lévy P
Ann Surg; 2014 Aug; 260(2):364-71. PubMed ID: 24646561
[TBL] [Abstract][Full Text] [Related]
8. Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making.
Marchegiani G; Crippa S; Perri G; Rancoita PMV; Caravati A; Belfiori G; Dall'Olio T; Aleotti F; Partelli S; Bassi C; Falconi M; Salvia R
Ann Surg Oncol; 2022 May; 29(5):3206-3214. PubMed ID: 35072863
[TBL] [Abstract][Full Text] [Related]
9. Intraductal papillary mucinous neoplasm--when to resect?
Waters JA; Schmidt CM
Adv Surg; 2008; 42():87-108. PubMed ID: 18953811
[TBL] [Abstract][Full Text] [Related]
10. Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicenter, retrospective study of 1074 IPMN patients by the Japan Pancreas Society.
Hirono S; Shimizu Y; Ohtsuka T; Kin T; Hara K; Kanno A; Koshita S; Hanada K; Kitano M; Inoue H; Itoi T; Ueki T; Shimokawa T; Hijioka S; Yanagisawa A; Nakamura M; Okazaki K; Yamaue H
J Gastroenterol; 2020 Jan; 55(1):86-99. PubMed ID: 31463655
[TBL] [Abstract][Full Text] [Related]
11. [Limited pancreatic resections for intraductal papillary mucinous neoplasm].
Blanc B; Sauvanet A; Couvelard A; Pessaux P; Dokmak S; Vullierme MP; Lévy P; Ruszniewski P; Belghiti J
J Chir (Paris); 2008; 145(6):568-78. PubMed ID: 19106888
[TBL] [Abstract][Full Text] [Related]
12. Data analysis of 36 cases with intraductal papillary mucinous neoplasm of the pancreas for their clinicopathological features, diagnosis, and treatment.
Yuan C; Xiu D; Tao M; Ma Z; Jiang B; Li Z; Li L; Wang L; Wang H; Zhang T
Chin Med J (Engl); 2014; 127(23):4087-91. PubMed ID: 25430454
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.
Attiyeh MA; Fernández-Del Castillo C; Al Efishat M; Eaton AA; Gönen M; Batts R; Pergolini I; Rezaee N; Lillemoe KD; Ferrone CR; Mino-Kenudson M; Weiss MJ; Cameron JL; Hruban RH; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Wolfgang CL; Allen PJ
Ann Surg; 2018 Jan; 267(1):157-163. PubMed ID: 28079542
[TBL] [Abstract][Full Text] [Related]
14. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
[TBL] [Abstract][Full Text] [Related]
15. Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection.
Fuji T; Umeda Y; Takagi K; Yoshida R; Yoshida K; Yasui K; Matsumoto K; Kato H; Yagi T; Fujiwara T
BMC Cancer; 2022 May; 22(1):588. PubMed ID: 35643422
[TBL] [Abstract][Full Text] [Related]
16. Long-term prospective cohort study of patients undergoing pancreatectomy for intraductal papillary mucinous neoplasm of the pancreas: implications for postoperative surveillance.
Kang MJ; Jang JY; Lee KB; Chang YR; Kwon W; Kim SW
Ann Surg; 2014 Aug; 260(2):356-63. PubMed ID: 24378847
[TBL] [Abstract][Full Text] [Related]
17. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
[TBL] [Abstract][Full Text] [Related]
18. Side-branch intraductal papillary mucinous neoplasms of the pancreatic head/uncinate: resection or enucleation?
Turrini O; Schmidt CM; Pitt HA; Guiramand J; Aguilar-Saavedra JR; Aboudi S; Lillemoe KD; Delpero JR
HPB (Oxford); 2011 Feb; 13(2):126-31. PubMed ID: 21241430
[TBL] [Abstract][Full Text] [Related]
19. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
20. Management and outcomes of intraductal papillary mucinous neoplasms.
Hipp J; Mohamed S; Pott J; Sick O; Makowiec F; Hopt UT; Fichtner-Feigl S; Wittel UA
BJS Open; 2019 Aug; 3(4):490-499. PubMed ID: 31388641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
